Summary

The global laboratory freezers market is projected to reach USD 5.11 billion by 2031 from USD 4.32 billion in 2026, at a CAGR of 3.5% from 2026 to 2031. The laboratory freezers market is primarily driven by the increasing need for reliable, temperature-controlled storage of vaccines, biological samples, reagents, blood components, cell lines, tissues, and other temperature-sensitive materials. The rapid expansion of pharmaceutical and biotechnology research, vaccine development, clinical diagnostics, biobanking, genomics, and cell and gene therapy is accelerating the adoption of advanced laboratory freezers across research institutes, hospitals, diagnostic laboratories, pharmaceutical companies, and biobanks. In addition, stringent regulatory and quality requirements for maintaining sample integrity and cold-chain compliance are encouraging end users to adopt freezers equipped with precise temperature control, continuous monitoring, automated data logging, remote alarms, and backup systems. Furthermore, increasing investments in healthcare and life-science infrastructure, the expansion of biorepositories, and growing demand for ultra-low-temperature storage are supporting market growth. Manufacturers are also introducing energy-efficient compressors, environmentally sustainable refrigerants, improved insulation, automated inventory management, and IoT-enabled monitoring systems to reduce operating costs, minimize sample-loss risks, and enhance laboratory workflow efficiency, thereby driving sustained growth of the laboratory freezers market. By product, refrigerators accounted for the largest share of the laboratory freezers market in 2025. By product, the laboratory freezers market is segmented into freezers, refrigerators, and cryopreservation systems. Refrigerators account for the largest market share due to their widespread use for the routine storage of vaccines, reagents, culture media, pharmaceutical products, blood samples, and other temperature-sensitive materials at controlled temperatures, typically between 2°C and 8°C. Their extensive installation across hospitals, diagnostic laboratories, blood banks, pharmacies, research institutes, and pharmaceutical and biotechnology companies generates strong and recurring demand. Compared with ultra-low-temperature freezers and cryopreservation systems, laboratory refrigerators offer lower acquisition and operating costs, simpler maintenance, and broader applicability in everyday laboratory workflows. Furthermore, expanding diagnostic testing, vaccine programs, clinical research, and pharmaceutical production—along with stringent requirements for temperature stability, continuous monitoring, automated data logging, and regulatory compliance are supporting the segment’s leading position. Growing adoption of energy-efficient, environmentally sustainable, and IoT-enabled refrigerators with remote alarms and backup controls is expected to further drive segment growth. By application, the pharmaceutical & vaccine storage segment accounted for the largest share of the laboratory freezers market. By application, the laboratory freezers market is segmented into environmental testing, genetic material storage, pharmaceutical & vaccine storage, biological samples & inventory management, and other applications. The pharmaceutical & vaccine storage segment accounted for the largest market share owing to the substantial volume of temperature-sensitive vaccines, biologics, drugs, active pharmaceutical ingredients, reagents, and clinical-trial materials requiring controlled storage. The expansion of vaccine manufacturing and immunization programs, increasing production of biologics and specialty medicines, and growth in pharmaceutical research and clinical trials are creating strong demand for laboratory refrigerators and freezers. Furthermore, stringent regulatory requirements for temperature stability, continuous monitoring, data logging, alarm systems, backup power, and cold-chain compliance encourage pharmaceutical manufacturers, hospitals, pharmacies, research laboratories, and distribution centers to invest in reliable storage equipment. The recurring need to store pharmaceutical products across research, production, quality-control, and distribution workflows further reinforces the segment’s leading market position. By end user, pharmaceutical & biotechnology companies accounted for the largest share in the forecast period. By end user, the laboratory freezers market is segmented into hospitals, clinical & pathology laboratories, pharmaceutical & biotechnology companies, academic & research institutes, pharmacies & physicians’ offices, and cell & tissue banks. Pharmaceutical & biotechnology companies accounted for the largest market share due to their extensive requirement for controlled-temperature storage across drug discovery, vaccine development, biologics manufacturing, clinical trials, quality control, and commercial production. These companies store substantial volumes of temperature-sensitive materials, including vaccines, biologics, cell lines, genetic material, reagents, active pharmaceutical ingredients, reference standards, and clinical-trial samples. Rising investment in biopharmaceutical R&D, expanding biologics and biosimilar pipelines, and the development of cell and gene therapies are further increasing demand for refrigerators, ultra-low-temperature freezers, and cryopreservation systems. Moreover, stringent regulatory requirements for sample integrity, temperature monitoring, data logging, alarm management, backup systems, and storage validation support the segment’s leading market position. The Asia Pacific market is projected to show the highest growth rate in the laboratory freezers market. The laboratory freezers market spans five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Asia Pacific is projected to register the highest growth rate, driven by the rapid expansion of pharmaceutical and biotechnology manufacturing, vaccine production, clinical research, diagnostic testing, and biobanking activities. Increasing healthcare expenditure, government investments in life-science infrastructure, and the establishment of new research laboratories, hospitals, and cold-chain facilities are strengthening demand for laboratory refrigerators, ultra-low-temperature freezers, and cryopreservation systems. The region is also benefiting from the growing production of biologics, biosimilars, and cell and gene therapies, particularly in China, India, Japan, and South Korea. Furthermore, increasing awareness of sample integrity, stricter temperature-control requirements, and rising adoption of energy-efficient and digitally connected storage systems are expected to accelerate regional market growth. A breakdown of the primary participants referred to for this report is provided below: ・ By Company Type: Tier 1 (45%), Tier 2 (35%), and Tier 3 (20%) ・ By Designation: Directors (50%), Managers (30%), and Others (20%) ・ By Region: North America (37%), Europe (25%), Asia Pacific (30%), Latin America (5%), and the Middle East & Africa (3%) The major players in the laboratory freezers market include Thermo Fisher Scientific (US), Haier Biomedical (China), PHC Holdings (Japan), Eppendorf AG (Germany), and Avantor (US), among others Research Coverage The research report examines the laboratory freezers market by product, application, end user, and region. This research covers factors driving market expansion, analyzes prospects and parameters faced by industries today, and provides specifics on the competitive landscape, considering market leaders and small and medium enterprises. This research also estimates the revenue of different market segments by considering five regions and micromarket analysis Reasons to Buy the Report The report will provide market leaders and new entrants with valuable information regarding the revenue estimates for the overall laboratory freezers market and its subsegments. It will help stakeholders understand the competitive landscape, allowing them to position their businesses more effectively and develop appropriate go-to-market strategies. Additionally, the report offers insights into the market dynamics, including key drivers, restraints, challenges, and opportunities. This report provides insightful data on the following pointers: ・ Market Penetration: In-depth coverage of product portfolios offered by the top players in the laboratory freezers market ・ Product Development/Innovation: Detailed insights into upcoming technologies, research & development activities, and product & service launches in the laboratory freezers market ・ Market Development: Insightful data on profitable developing areas ・ Market Diversification: Details about recent developments and advancements in the laboratory freezers market ・ Competitive Assessment: Extensive assessment of the products, growth tactics, revenue projections, and market categories of the top competitors

ページTOPに戻る

Table of Contents

1 INTRODUCTION 23 1.1 STUDY OBJECTIVES 23 1.2 MARKET DEFINITION 23 1.3 MARKET SCOPE 24 1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE 24 1.3.2 INCLUSIONS AND EXCLUSIONS 25 1.3.3 YEARS CONSIDERED 25 1.4 CURRENCY CONSIDERED 26 1.5 STAKEHOLDERS 26 1.6 SUMMARY OF CHANGES 26 2 EXECUTIVE SUMMARY 27 2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS 27 2.2 DISRUPTIVE TRENDS IN LABORATORY FREEZERS MARKET 29 2.3 HIGH GROWTH SEGMENTS 30 2.4 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 31 3 PREMIUM INSIGHTS 32 3.1 LABORATORY FREEZERS MARKET OVERVIEW 32 3.2 NORTH AMERICA: LABORATORY FREEZERS MARKET, BY COUNTRY AND PRODUCT, 2025 33 3.3 GEOGRAPHIC SNAPSHOT OF LABORATORY FREEZERS MARKET 34 4 MARKET OVERVIEW 35 4.1 INTRODUCTION 35 4.2 MARKET DYNAMICS 36 4.2.1 DRIVERS 36 4.2.1.1 Expanding life science research and temperature-sensitive biologics storage 36 4.2.1.2 Expanding vaccine and biopharmaceutical production drives demand for validated frozen-storage infrastructure 37 4.2.2 RESTRAINTS 37 4.2.2.1 High capital and lifecycle costs of advanced freezers 37 4.2.2.2 Tightening refrigerant regulations that increase compliance costs 37 4.2.3 OPPORTUNITIES 38 4.2.3.1 Transition to natural-refrigerant and HFC-free cooling technologies 38 4.2.3.2 Growing clinical-trial activity to expand decentralized sample-storage requirements 39 4.2.4 CHALLENGES 39 4.2.4.1 Maintaining temperature uniformity and sample integrity 39 4.2.4.2 Stringent validation and documentation requirements 40 5 INDUSTRY TRENDS 41 5.1 PORTER’S FIVE FORCES ANALYSIS 41 5.1.1 BARGAINING POWER OF BUYERS 42 5.1.2 BARGAINING POWER OF SUPPLIERS 42 5.1.3 THREAT OF NEW ENTRANTS 42 5.1.4 THREAT OF SUBSTITUTES 42 5.1.5 INTENSITY OF COMPETITIVE RIVALRY 42 5.2 MACROECONOMIC INDICATORS 42 5.2.1 GDP TRENDS AND FORECAST 43 5.2.2 TRENDS IN GLOBAL LABORATORY FREEZERS INDUSTRY 44 5.3 SUPPLY CHAIN ANALYSIS 44 5.3.1 PROMINENT COMPANIES 45 5.3.2 SMALL AND MEDIUM-SIZED ENTERPRISES 45 5.3.3 END USERS 45 5.4 VALUE CHAIN ANALYSIS 45 5.4.1 RESEARCH & DEVELOPMENT 46 5.4.2 RAW MATERIAL PROCUREMENT & PRODUCT DEVELOPMENT 46 5.4.3 MARKETING, SALES, AND DISTRIBUTION 47 5.5 ECOSYSTEM ANALYSIS 47 5.6 PRICING ANALYSIS 48 5.6.1 AVERAGE SELLING PRICE OF LABORATORY FREEZERS, BY KEY PLAYER, 2025 48 5.6.2 AVERAGE SELLING PRICE OF PRODUCT, BY KEY PLAYER, 2023–2025 (USD) 48 5.6.3 AVERAGE SELLING PRICE TREND, BY REGION, 2025 49 5.7 TRADE ANALYSIS 51 5.7.1 IMPORT DATA FOR HS CODE 841840 51 5.7.2 IMPORT DATA FOR FREEZERS OF THE UPRIGHT TYPE, OF A CAPACITY <= 900 L (HS CODE 841840) 52 5.7.3 EXPORT DATA FOR FREEZERS OF THE UPRIGHT TYPE, OF A CAPACITY <= 900 L (HS CODE 841840) 52 5.8 KEY CONFERENCES & EVENTS, 2026–2027 53 5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 54 5.9.1 DIGITAL MONITORING, SUSTAINABILITY, AND EXPANDING APPLICATIONS TRANSFORM MARKET 54 5.10 INVESTMENT & FUNDING SCENARIO 55 5.11 CASE STUDY ANALYSIS 57 5.11.1 CASE STUDY 57 5.12 IMPACT OF 2025 US TARIFF ON LABORATORY FREEZERS MARKET 58 5.12.1 INTRODUCTION 58 5.12.2 KEY TARIFF RATES 58 5.12.3 KEY TARIFF RATES 58 5.12.4 PRICE IMPACT ANALYSIS 59 5.12.5 IMPACT ON COUNTRY/REGION 59 5.12.5.1 US 59 5.12.5.2 Europe 59 5.12.5.3 Asia Pacific 59 5.12.6 IMPACT ON END USERS 60 6 STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTION 61 6.1 KEY EMERGING TECHNOLOGIES 61 6.1.1 NATURAL/ECO-FRIENDLY REFRIGERANTS 61 6.1.2 SMART/IOT-ENABLED FREEZERS 61 6.2 COMPLEMENTARY TECHNOLOGIES 61 6.2.1 TEMPERATURE-CONTROLLED TRANSPORT SYSTEMS 61 6.2.2 BUILDING-MANAGEMENT-SYSTEM INTEGRATION 61 6.2.3 ROBOTIC AND AUTOMATED SAMPLE-STORAGE SYSTEMS 61 6.3 PATENT ANALYSIS 62 6.4 IMPACT OF AI/GEN AI ON LABORATORY FREEZERS MARKET 63 6.4.1 TOP USE CASES AND MARKET POTENTIAL 64 6.4.2 BEST PRACTICES IN LABORATORY FREEZERS 65 6.4.3 CASE STUDIES OF AI IMPLEMENTATION IN LABORATORY FREEZERS MARKET 65 6.4.4 INTERCONNECTED ADJACENT ECOSYSTEMS AND IMPACT ON MARKET PLAYERS 66 6.4.5 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN LABORATORY FREEZERS MARKET 66 6.5 SUCCESS STORIES AND REAL-WORLD APPLICATIONS 67 7 REGULATORY LANDSCAPE 68 7.1 REGULATORY TRENDS 68 7.1.1 NORTH AMERICA 68 7.1.1.1 US 68 7.1.1.2 Canada 69 7.1.2 EUROPE 70 7.1.3 ASIA PACIFIC 71 7.1.3.1 Japan 71 7.1.3.2 China 71 7.1.3.3 India 73 7.2 KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74 7.2.1 NORTH AMERICA 74 7.2.2 EUROPE 74 7.2.3 ASIA PACIFIC 75 7.2.4 LATIN AMERICA 76 7.2.5 MIDDLE EAST & AFRICA 76 7.3 INDUSTRY STANDARDS 77 8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR 78 8.1 DECISION-MAKING PROCESS 78 8.2 KEY STAKEHOLDERS & BUYING CRITERIA 78 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 79 8.2.2 KEY BUYING CRITERIA 80 8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES 80 8.4 UNMET NEEDS OF VARIOUS END USERS 81 9 LABORATORY FREEZERS MARKET, BY PRODUCT 83 9.1 INTRODUCTION 84 9.2 FREEZERS 84 9.2.1 ULTRA-LOW-TEMPERATURE FREEZERS 85 9.2.1.1 Expanding biobanking and cell & gene therapy pipelines drive demand 85 9.2.2 GENERAL-PURPOSE FREEZERS 86 9.2.2.1 Increased clinical and diagnostic test volume to drive market growth 86 9.2.3 PLASMA FREEZERS 87 9.2.3.1 Rising blood component demand and trauma care needs sustain segment growth 87 9.2.4 ENZYME FREEZERS 88 9.2.4.1 Expansion of biotechnology research and enzyme-based diagnostics to drive demand 88 9.2.5 EXPLOSION-PROOF FREEZERS 88 9.2.5.1 Tightening laboratory safety codes accelerate adoption of hazardous-location freezer design 88 9.2.6 FLAMMABLE MATERIAL FREEZERS 89 9.2.6.1 Expanding chemical inventories in research and pharma labs boost demand for dedicated flammable storage 89 9.3 REFRIGERATORS 90 9.3.1 BLOOD BANK REFRIGERATORS 91 9.3.1.1 Growing blood donation networks and trauma caseloads fuel demand 91 9.3.2 CHROMATOGRAPHY REFRIGERATORS 91 9.3.2.1 Precision temperature control for analytical workflows expand segment 91 9.3.3 EXPLOSION-PROOF REFRIGERATORS 92 9.3.3.1 Hazardous-location certification needs enhance demand in R&D labs 92 9.3.4 FLAMMABLE MATERIAL REFRIGERATORS 93 9.3.4.1 Stricter chemical safety compliance drives lab upgrades 93 9.3.5 LABORATORY REFRIGERATORS 93 9.3.5.1 Energy-efficient lab refrigerator to grow market 93 9.3.6 PHARMACY REFRIGERATORS 94 9.3.6.1 Expansion of pharmacy-based vaccination services drives purpose-built cold storage demand 94 9.4 CRYOPRESERVATION SYSTEMS 95 9.4.1 NEED FOR APPROPRIATE CRYOPRESERVATION STORAGE SYSTEMS TO ENSURE SAMPLE INTEGRITY BOOSTS SEGMENT GROWTH 95 10 LABORATORY FREEZERS MARKET, BY APPLICATION 96 10.1 INTRODUCTION 97 10.2 ENVIRONMENTAL TESTING 97 10.2.1 REFORMS IN ENVIRONMENTAL TESTING NORMS TO DRIVE DEMAND 97 10.3 GENETIC MATERIAL STORAGE 98 10.3.1 INCREASED RESEARCH INVESTMENTS IN OMICS RESEARCH TO DRIVE MARKET GROWTH 98 10.4 PHARMACEUTICAL & VACCINE STORAGE 99 10.4.1 TEMPERATURE-SENSITIVE REQUIREMENTS IN DRUG AND VACCINE MANUFACTURING TO DRIVE SEGMENT 99 10.5 BIOLOGICAL SAMPLES & INVENTORY MANAGEMENT 100 10.5.1 GROWTH IN SAMPLE VOLUME TO DRIVE DEMAND FOR REFRIGERATORS 100 10.6 OTHER APPLICATIONS 101 10.6.1 RAPID-RESPONSE COLD STORAGE DRIVING REPLACEMENT DEMAND ACROSS BLOOD BANKS AND TRANSFUSION SERVICES 101 11 LABORATORY FREEZERS MARKET, BY END USER 102 11.1 INTRODUCTION 103 11.2 HOSPITALS 104 11.2.1 RAPID-RESPONSE COLD STORAGE DRIVES REPLACEMENT DEMAND ACROSS EMERGENCY, ONCOLOGY, AND SURGICAL CARE 104 11.3 CLINICAL & PATHOLOGY LABORATORIES 104 11.3.1 DIGITAL PATHOLOGY AND AUTOMATION TO DRIVE MARKET GROWTH IN CLINICAL LABORATORIES 104 11.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 105 11.4.1 GMP-COMPLIANT ULTRA-LOW TEMPERATURE STORAGE SCALING TO DRIVE GROWTH 105 11.5 ACADEMIC & RESEARCH INSTITUTES 106 11.5.1 GREEN-LAB AND ENERGY-REDUCTION INITIATIVES RESHAPING FREEZER PROCUREMENT AND OPERATING PRACTICES 106 11.6 PHARMACIES & PHYSICIANS’ OFFICES 107 11.6.1 COMPLIANCE REQUIREMENTS FOR CHILDREN’S VACCINES TO BOOST SEGMENT 107 11.7 CELL & TISSUE BANKS 108 11.7.1 INCREASED ADOPTION OF FREEZERS IN MOLECULAR DIAGNOSTICS TO DRIVE MARKET EXPANSION 108 11.8 ENVIRONMENTAL LABS 109 11.8.1 INCREASED ADOPTION DUE TO STRICTER ENVIRONMENTAL MONITORING PROGRAMS 109 11.9 FORENSIC LABS 110 11.9.1 COLD-CASE RETESTING AND DNA EVIDENCE INTEGRITY REINFORCE LONG-TERM FROZEN STORAGE PROTOCOLS 110 11.10 FOOD & BEVERAGE COMPANIES 110 11.10.1 STRICT QUALITY CONTROL REQUIREMENTS TO DRIVE DEMAND 110 11.11 OTHER END USERS 111 11.11.1 LONG-TERM SAMPLE PRESERVATION TO DRIVE MARKET GROWTH IN OTHER END USERS 111 12 LABORATORY FREEZERS MARKET, BY REGION 112 12.1 INTRODUCTION 113 12.2 NORTH AMERICA 113 12.2.1 US 117 12.2.1.1 Established biopharma & R&D landscape to drive replacement cycle 117 12.2.2 CANADA 118 12.2.2.1 Growth in pharmaceutical R&D sector to grow demand for cold storage technologies 118 12.3 EUROPE 119 12.3.1 GERMANY 122 12.3.1.1 Strong local manufacturing footprints and established research infrastructure to drive market growth 122 12.3.2 UK 122 12.3.2.1 UKRI investments and national research infrastructure to fuel lab freezers adoption 122 12.3.3 FRANCE 123 12.3.3.1 Large research & development base to grow demand for cold storage samples 123 12.3.4 ITALY 124 12.3.4.1 Industry-academia partnership to drive market growth 124 12.3.5 SPAIN 124 12.3.5.1 Large clinical research base to drive freezer demand 124 12.3.6 REST OF EUROPE 125 12.4 ASIA PACIFIC 126 12.4.1 JAPAN 130 12.4.1.1 Increased investments in pharma manufacturing to drive market 130 12.4.2 CHINA 130 12.4.2.1 National GeneBank expansion and localized manufacturing scale to drive market growth 130 12.4.3 INDIA 131 12.4.3.1 National phenome and genome project to scale up demand for cold storage equipment 131 12.4.4 AUSTRALIA 132 12.4.4.1 Strong biobank network to drive demand cold storage options in Australia 132 12.4.5 SOUTH KOREA 132 12.4.5.1 Academic and medical institutes to drive demand for laboratory refrigeration solutions 132 12.4.6 REST OF ASIA PACIFIC 133 12.5 LATIN AMERICA 134 12.5.1 BRAZIL 137 12.5.1.1 Fiocruz biobank network and regional manufacturing base – key drivers 137 12.5.2 MEXICO 137 12.5.2.1 Expansion in biopharmaceutical sector to boost market 137 12.5.3 REST OF LATIN AMERICA 138 12.6 MIDDLE EAST & AFRICA 139 12.6.1 GCC COUNTRIES 142 12.6.1.1 Government-led investments to grow market in GCC countries 142 12.6.2 REST OF MIDDLE EAST & AFRICA 142 13 COMPETITIVE LANDSCAPE 144 13.1 INTRODUCTION 144 13.2 KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN, 2023–2026 144 13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN LABORATORY FREEZERS MARKET 144 13.3 REVENUE ANALYSIS, 2021–2025 146 13.4 MARKET SHARE ANALYSIS, 2025 146 13.4.1 MARKET RANKING OF KEY PLAYERS, 2025 148 13.5 COMPANY VALUATION AND FINANCIAL METRICS 148 13.5.1 FINANCIAL METRICS 148 13.5.2 COMPANY VALUATION 149 13.6 BRAND/PRODUCT COMPARISON 150 13.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 151 13.7.1 STARS 151 13.7.2 EMERGING LEADERS 151 13.7.3 PERVASIVE PLAYERS 151 13.7.4 PARTICIPANTS 151 13.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 153 13.7.5.1 Company footprint 153 13.7.5.2 Region footprint 153 13.7.5.3 Product footprint 154 13.7.5.4 Application footprint 155 13.7.5.5 End user footprint 155 13.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 156 13.8.1 PROGRESSIVE COMPANIES 156 13.8.2 RESPONSIVE COMPANIES 156 13.8.3 DYNAMIC COMPANIES 156 13.8.4 STARTING BLOCKS 157 13.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 158 13.8.5.1 Detailed list of key startups/SMEs 158 13.8.5.2 Competitive benchmarking of key startups/SMEs 159 13.9 COMPETITIVE SCENARIO 161 13.9.1 PRODUCT LAUNCHES 161 13.9.2 DEALS 161 13.9.3 EXPANSIONS 162 14 COMPANY PROFILES 163 14.1 KEY PLAYERS 163 14.1.1 THERMO FISHER SCIENTIFIC INC. 163 14.1.1.1 Business overview 163 14.1.1.2 Products offered 164 14.1.1.3 Recent developments 165 14.1.1.3.1 Product launches 165 14.1.1.3.2 Expansions 166 14.1.1.4 MnM view 166 14.1.1.4.1 Right to win 166 14.1.1.4.2 Strategic choices 166 14.1.1.4.3 Weaknesses & competitive threats 166 14.1.2 HAIER BIOMEDICAL 167 14.1.2.1 Business overview 167 14.1.2.2 Products offered 168 14.1.2.3 Recent developments 169 14.1.2.3.1 Product launches 169 14.1.2.3.2 Deals 169 14.1.2.4 MnM view 170 14.1.2.4.1 Right to win 170 14.1.2.4.2 Strategic choices 170 14.1.2.4.3 Weaknesses & competitive threats 170 14.1.3 PHC HOLDINGS CORPORATION 171 14.1.3.1 Business overview 171 14.1.3.2 Products offered 172 14.1.3.3 Recent developments 173 14.1.3.3.1 Product launches 173 14.1.3.4 MnM view 174 14.1.3.4.1 Right to win 174 14.1.3.4.2 Strategic choices 174 14.1.3.4.3 Weaknesses & competitive threats 174 14.1.4 EPPENDORF SE 175 14.1.4.1 Business overview 175 14.1.4.2 Products offered 176 14.1.4.3 Recent developments 177 14.1.4.3.1 Product launches & approvals 177 14.1.4.3.2 Deals 177 14.1.4.3.3 Expansions 178 14.1.4.4 MnM view 178 14.1.4.4.1 Right to win 178 14.1.4.4.2 Strategic choices 178 14.1.4.4.3 Weaknesses & competitive threats 178 14.1.5 AVANTOR, INC. 179 14.1.5.1 Business overview 179 14.1.5.2 Products offered 180 14.1.5.3 Recent developments 181 14.1.5.3.1 Deals 181 14.1.6 HELMER SCIENTIFIC 182 14.1.6.1 Business overview 182 14.1.6.2 Products offered 182 14.1.6.3 Recent developments 183 14.1.6.3.1 Product launches & approvals 183 14.1.7 FOLLETT PRODUCTS, LLC 184 14.1.7.1 Business overview 184 14.1.7.2 Products offered 186 14.1.8 LIEBHERR 187 14.1.8.1 Business overview 187 14.1.8.2 Products offered 189 14.1.8.3 Recent developments 189 14.1.8.3.1 Product launches & approvals 189 14.1.9 FELIX STORCH, INC. 190 14.1.9.1 Business overview 190 14.1.9.2 Products offered 190 14.1.10 CUSTOM BIOGENIC SYSTEMS 191 14.1.10.1 Business overview 191 14.1.10.2 Products offered 191 14.1.11 BLUE STAR LIMITED 192 14.1.11.1 Business overview 192 14.1.11.2 Products offered 193 14.1.12 PHILIPP KIRSCH GMBH 194 14.1.12.1 Business overview 194 14.1.12.2 Products offered 194 14.2 OTHER PLAYERS 195 14.2.1 SO-LOW ENVIRONMENTAL EQUIPMENT CO. LTD 195 14.2.2 JEIO TECH 196 14.2.3 STERICOX INDIA PRIVATE LIMITED 197 14.2.4 THALHEIMER KÜHLUNG FEZO 198 14.2.5 B MEDICAL SYSTEMS 199 14.2.6 STANDEX INTERNATIONAL CORPORATION 200 14.2.7 EVERMED S.R.L 201 14.2.8 ARCTIKO 202 14.2.9 VESTFROST SOLUTIONS 203 14.2.10 KW TECNILABO 204 14.2.11 COLE PARMER 205 14.2.12 ZHONGKE MEILING CRYOGENICS COMPANY LIMITED 206 14.2.13 ESAW INDIA 207 15 RESEARCH METHODOLOGY 208 15.1 RESEARCH DATA 208 15.1.1 SECONDARY RESEARCH 209 15.1.1.1 Key secondary sources 211 15.1.1.2 Key data from secondary sources 211 15.1.2 PRIMARY RESEARCH 212 15.1.2.1 Key primary sources 212 15.1.2.2 Key supply- and demand-side participants 212 15.1.2.3 Breakdown of primary interviews 213 15.1.2.4 Key primary insights 214 15.2 MARKET SIZE ESTIMATION METHODOLOGY 214 15.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION 215 15.2.2 END-USER-BASED MAPPING MARKET ESTIMATION 217 15.3 GROWTH FORECASTING MODEL 218 15.4 DATA TRIANGULATION AND MARKET BREAKDOWN 219 15.5 RESEARCH ASSUMPTIONS 220 15.6 RESEARCH LIMITATIONS 220 15.7 RISK ANALYSIS 221 16 APPENDIX 222 16.1 DISCUSSION GUIDE 222 16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 226 16.3 CUSTOMIZATION OPTIONS 228 16.4 RELATED REPORTS 228 16.5 AUTHOR DETAILS 229

ページTOPに戻る

List of Tables/Graphs

TABLE 1 LABORATORY FREEZERS MARKET: INCLUSIONS AND EXCLUSIONS OF STUDY 25.
TABLE 2 IMPACT OF PORTER’S FIVE FORCES ON LABORATORY FREEZERS MARKET 41.
TABLE 3 AVERAGE SELLING PRICE OF LABORATORY FREEZERS, BY REGION, 2023–2025 (USD) 50.
TABLE 4 IMPORT DATA FOR FREEZERS OF THE UPRIGHT TYPE (HS CODE 841840), BY COUNTRY, 2021–2025 (USD MILLION) 52.
TABLE 5 EXPORT DATA FOR FREEZERS OF THE UPRIGHT TYPE (HS CODE 841840), BY COUNTRY, 2021–2025 (USD MILLION) 53.
TABLE 6 LABORATORY FREEZERS MARKET: KEY CONFERENCES AND EVENTS, 2026–2027 53.
TABLE 7 CASE STUDY 1: REMOTE MONITORING IMPROVES ULT FREEZER FLEET MANAGEMENT 57.
TABLE 8 CASE STUDY 2: PHCBI’S −86°C ULT FREEZER SUPPORTS LONG-TERM SAMPLE STORAGE FOR SEPSIS RESEARCH 57.
TABLE 9 US ADJUSTED RECIPROCAL TARIFF RATES 58.
TABLE 10 LABORATORY FREEZERS MARKET: KEY PATENT REGISTRATIONS, 2025-2026 63.
TABLE 11 CASE STUDY 1: AI-BASED THERMAL MODELING FOR ULTRA-LOW-TEMPERATURE FREEZERS 65.
TABLE 12 CASE STUDY 2: AI- AND CLOUD-ENABLED MONITORING FOR ULT FREEZERS 65.
TABLE 13 INTERCONNECTED ADJACENT ECOSYSTEMS AND IMPACT ON MARKET PLAYERS 66.
TABLE 14 MEDICAL DEVICE CLASSIFICATION BY US FDA 68.
TABLE 15 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 69.
TABLE 16 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 69.
TABLE 17 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PHARMACEUTICAL AND MEDICAL DEVICE AGENCY 71.
TABLE 18 CHINA: CLASSIFICATION OF MEDICAL DEVICES 72.
TABLE 19 NORTH AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74.
TABLE 20 EUROPE: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74.
TABLE 21 ASIA PACIFIC: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 75.
TABLE 22 LATIN AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76.
TABLE 23 MIDDLE EAST & AFRICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76.
TABLE 24 INDUSTRY STANDARDS FOR LABORATORY FREEZERS MARKET 77.
TABLE 25 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS IN LABORATORY FREEZERS MARKET, BY PRODUCT (%) 79.
TABLE 26 KEY BUYING CRITERIA FOR LABORATORY FREEZER PRODUCTS 80.
TABLE 27 LABORATORY FREEZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 84.
TABLE 28 FREEZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 85.
TABLE 29 FREEZERS MARKET, BY REGION, 2024–2031 (USD MILLION) 85.
TABLE 30 ULTRA-LOW-TEMPERATURE FREEZERS MARKET, BY REGION, 2024–2031 (USD MILLION) 86.
TABLE 31 GENERAL-PURPOSE FREEZERS MARKET, BY REGION, 2024–2031 (USD MILLION) 87.
TABLE 32 PLASMA FREEZERS MARKET, BY REGION, 2024–2031 (USD MILLION) 87.
TABLE 33 ENZYME FREEZERS MARKET, BY REGION, 2024–2031 (USD MILLION) 88.
TABLE 34 EXPLOSION-PROOF FREEZERS MARKET, BY REGION, 2024–2031 (USD MILLION) 89.
TABLE 35 FLAMMABLE MATERIAL FREEZERS MARKET, BY REGION, 2024–2031 (USD MILLION) 89.
TABLE 36 REFRIGERATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 90.
TABLE 37 REFRIGERATORS MARKET, BY REGION, 2024–2031 (USD MILLION) 90.
TABLE 38 BLOOD BANK REFRIGERATORS MARKET, BY REGION, 2024–2031 (USD MILLION) 91.
TABLE 39 CHROMATOGRAPHY REFRIGERATORS MARKET, BY REGION, 2024–2031 (USD MILLION) 92.
TABLE 40 EXPLOSION-PROOF REFRIGERATORS MARKET, BY REGION, 2024–2031 (USD MILLION) 92.
TABLE 41 FLAMMABLE MATERIAL REFRIGERATORS MARKET, BY REGION, 2024–2031 (USD MILLION) 93.
TABLE 42 LABORATORY REFRIGERATORS MARKET, BY REGION, 2024–2031 (USD MILLION) 94.
TABLE 43 PHARMACY REFRIGERATORS MARKET, BY REGION, 2024–2031 (USD MILLION) 94.
TABLE 44 CRYOPRESERVATION SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 95.
TABLE 45 LABORATORY FREEZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 97.
TABLE 46 LABORATORY FREEZERS MARKET FOR ENVIRONMENTAL TESTING, BY REGION, 2024–2031 (USD MILLION) 98.
TABLE 47 LABORATORY FREEZERS MARKET FOR GENETIC MATERIAL STORAGE, BY REGION, 2024–2031 (USD MILLION) 99.
TABLE 48 LABORATORY FREEZERS MARKET FOR PHARMACEUTICAL & VACCINE STORAGE, BY REGION, 2024–2031 (USD MILLION) 100.
TABLE 49 LABORATORY FREEZERS MARKET FOR BIOLOGICAL SAMPLES & INVENTORY MANAGEMENT, BY REGION, 2024–2031 (USD MILLION) 100.
TABLE 50 LABORATORY FREEZERS MARKET FOR OTHER APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 101.
TABLE 51 LABORATORY FREEZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 103.
TABLE 52 LABORATORY FREEZERS MARKET FOR HOSPITALS, BY REGION, 2024–2031 (USD MILLION) 104.
TABLE 53 LABORATORY FREEZERS MARKET FOR CLINICAL & PATHOLOGY LABORATORIES, BY REGION, 2024–2031 (USD MILLION) 105.
TABLE 54 LABORATORY FREEZERS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION) 106.
TABLE 55 LABORATORY FREEZERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION) 107.
TABLE 56 LABORATORY FREEZERS MARKET FOR PHARMACIES & PHYSICIANS’ OFFICES, BY REGION, 2024–2031 (USD MILLION) 108.
TABLE 57 LABORATORY FREEZERS MARKET FOR CELL & TISSUE BANKS, BY REGION, 2024–2031 (USD MILLION) 109.
TABLE 58 LABORATORY FREEZERS MARKET FOR ENVIRONMENTAL LABS, BY REGION, 2024–2031 (USD MILLION) 109.
TABLE 59 LABORATORY FREEZERS MARKET FOR FORENSIC LABS, BY REGION, 2024–2031 (USD MILLION) 110.
TABLE 60 LABORATORY FREEZERS MARKET FOR FOOD & BEVERAGE COMPANIES, BY REGION, 2024–2031 (USD MILLION) 111.
TABLE 61 LABORATORY FREEZERS MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION) 111.
TABLE 62 LABORATORY FREEZERS MARKET, BY REGION, 2024–2031 (USD MILLION) 113.
TABLE 63 NORTH AMERICA: LABORATORY FREEZERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 114.
TABLE 64 NORTH AMERICA: LABORATORY FREEZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 115.
TABLE 65 NORTH AMERICA: FREEZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 115.
TABLE 66 NORTH AMERICA: REFRIGERATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 116.
TABLE 67 NORTH AMERICA: LABORATORY FREEZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 116.
TABLE 68 NORTH AMERICA: LABORATORY FREEZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 117.
TABLE 69 US: LABORATORY FREEZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 118.
TABLE 70 CANADA: LABORATORY FREEZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 118.
TABLE 71 EUROPE: LABORATORY FREEZERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 119.
TABLE 72 EUROPE: LABORATORY FREEZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 119.
TABLE 73 EUROPE: FREEZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 120.
TABLE 74 EUROPE: REFRIGERATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 120.
TABLE 75 EUROPE: LABORATORY FREEZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 121.
TABLE 76 EUROPE: LABORATORY FREEZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 121.
TABLE 77 GERMANY: LABORATORY FREEZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 122.
TABLE 78 UK: LABORATORY FREEZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 123.
TABLE 79 FRANCE: LABORATORY FREEZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 123.
TABLE 80 ITALY: LABORATORY FREEZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 124.
TABLE 81 SPAIN: LABORATORY FREEZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 125.
TABLE 82 REST OF EUROPE: LABORATORY FREEZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 125.
TABLE 83 ASIA PACIFIC: LABORATORY FREEZERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 127.
TABLE 84 ASIA PACIFIC: LABORATORY FREEZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 127.
TABLE 85 ASIA PACIFIC: FREEZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 128.
TABLE 86 ASIA PACIFIC: REFRIGERATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 128.
TABLE 87 ASIA PACIFIC: LABORATORY FREEZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 129.
TABLE 88 ASIA PACIFIC: LABORATORY FREEZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 129.
TABLE 89 JAPAN: LABORATORY FREEZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 130.
TABLE 90 CHINA: LABORATORY FREEZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 131.
TABLE 91 INDIA: LABORATORY FREEZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 131.
TABLE 92 AUSTRALIA: LABORATORY FREEZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 132.
TABLE 93 SOUTH KOREA: LABORATORY FREEZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 133.
TABLE 94 REST OF ASIA PACIFIC: LABORATORY FREEZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 133.
TABLE 95 LATIN AMERICA: LABORATORY FREEZERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 134.
TABLE 96 LATIN AMERICA: LABORATORY FREEZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 134.
TABLE 97 LATIN AMERICA: FREEZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 135.
TABLE 98 LATIN AMERICA: REFRIGERATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 135.
TABLE 99 LATIN AMERICA: LABORATORY FREEZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 136.
TABLE 100 LATIN AMERICA: LABORATORY FREEZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 136.
TABLE 101 BRAZIL: LABORATORY FREEZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 137.
TABLE 102 MEXICO: LABORATORY FREEZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 138.
TABLE 103 REST OF LATIN AMERICA: LABORATORY FREEZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 138.
TABLE 104 MIDDLE EAST & AFRICA: LABORATORY FREEZERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 139.
TABLE 105 MIDDLE EAST & AFRICA: LABORATORY FREEZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 139.
TABLE 106 MIDDLE EAST & AFRICA: FREEZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 140.
TABLE 107 MIDDLE EAST & AFRICA: REFRIGERATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 140.
TABLE 108 MIDDLE EAST & AFRICA: LABORATORY FREEZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 141.
TABLE 109 MIDDLE EAST & AFRICA: LABORATORY FREEZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 141.
TABLE 110 GCC COUNTRIES: LABORATORY FREEZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 142.
TABLE 111 REST OF MIDDLE EAST & AFRICA: LABORATORY FREEZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 143.
TABLE 112 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN LABORATORY FREEZERS MARKET, 2023–2026 144.
TABLE 113 LABORATORY FREEZERS MARKET: DEGREE OF COMPETITION 147.
TABLE 114 LABORATORY FREEZERS MARKET: REGION FOOTPRINT 153.
TABLE 115 LABORATORY FREEZERS MARKET: PRODUCT FOOTPRINT 154.
TABLE 116 LABORATORY FREEZERS MARKET: APPLICATION FOOTPRINT 155.
TABLE 117 LABORATORY FREEZERS MARKET: END USER FOOTPRINT 155.
TABLE 118 LABORATORY FREEZERS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 158.
TABLE 119 LABORATORY FREEZERS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, BY PRODUCT 159.
TABLE 120 LABORATORY FREEZERS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, BY REGION 160.
TABLE 121 LABORATORY FREEZERS MARKET: PRODUCT LAUNCHES, JANUARY 2023–JUNE 2026 161.
TABLE 122 LABORATORY FREEZERS MARKET: DEALS, JANUARY 2023–JUNE 2026 161.
TABLE 123 LABORATORY FREEZERS MARKET: EXPANSIONS, JANUARY 2023–JUNE 2026 162.
TABLE 124 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW 163.
TABLE 125 THERMO FISHER SCIENTIFIC INC: PRODUCTS OFFERED 164.
TABLE 126 THERMO FISHER SCIENTIFIC, INC: PRODUCT LAUNCHES, JANUARY 2023–JUNE 2026 165.
TABLE 127 THERMO FISHER SCIENTIFIC, INC: EXPANSIONS, JANUARY 2023–JUNE 2026 166.
TABLE 128 HAIER BIOMEDICAL: COMPANY OVERVIEW 167.
TABLE 129 HAIER BIOMEDICAL: PRODUCTS OFFERED 168.
TABLE 130 HAIER BIOMEDICAL: PRODUCT LAUNCHES, JANUARY 2023–JUNE 2026 169.
TABLE 131 HAIER BIOMEDICAL: DEALS, JANUARY 2023–JUNE 2026 169.
TABLE 132 PHC HOLDINGS CORPORATION: BUSINESS OVERVIEW 171.
TABLE 133 PHC HOLDINGS CORPORATION: PRODUCTS OFFERED 172.
TABLE 134 PHC HOLDINGS CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JUNE 2026 173.
TABLE 135 EPPENDORF SE: COMPANY OVERVIEW 175.
TABLE 136 EPPENDORF SE: PRODUCTS OFFERED 176.
TABLE 137 EPPENDORF SE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JUNE 2026 177.
TABLE 138 EPPENDORF SE: DEALS, JANUARY 2023–JUNE 2026 177.
TABLE 139 EPPENDORF SE: EXPANSIONS, JANUARY 2023–JUNE 2026 178.
TABLE 140 AVANTOR, INC.: COMPANY OVERVIEW 179.
TABLE 141 AVANTOR, INC.: PRODUCTS OFFERED 180.
TABLE 142 AVANTOR, INC.: DEALS, JANUARY 2023–JUNE 2026 181.
TABLE 143 HELMER SCIENTIFIC: COMPANY OVERVIEW 182.
TABLE 144 HELMER SCIENTIFIC: PRODUCTS OFFERED 182.
TABLE 145 HELMER SCIENTIFIC: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JUNE 2026 183.
TABLE 146 FOLLETT SCIENTIFIC: COMPANY OVERVIEW 184.
TABLE 147 FOLLETT SCIENTIFIC: PRODUCTS OFFERED 186.
TABLE 148 LIEBHERR: COMPANY OVERVIEW 187.
TABLE 149 LIEBHERR: PRODUCTS OFFERED 189.
TABLE 150 LIEBHERR : PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JUNE 2026 189.
TABLE 151 FELIX STORCH, INC.: COMPANY OVERVIEW 190.
TABLE 152 FELIX STORCH, INC.: PRODUCTS OFFERED 190.
TABLE 153 CUSTOM BIOGENIC SYSTEMS: COMPANY OVERVIEW 191.
TABLE 154 CUSTOM BIOGENIC SYSTEMS : PRODUCTS OFFERED 191.
TABLE 155 BLUE STAR LIMITED: COMPANY OVERVIEW 192.
TABLE 156 BLUE STAR LIMITED: PRODUCTS OFFERED 193.
TABLE 157 PHILIPP KIRSCH GMBH : COMPANY OVERVIEW 194.
TABLE 158 PHILIPP KIRSCH GMBH : PRODUCTS OFFERED 194.
TABLE 159 SO-LOW ENVIRONMENTAL EQUIPMENT CO. LTD: COMPANY OVERVIEW 195.
TABLE 160 JEIO TECH: COMPANY OVERVIEW 196.
TABLE 161 STERICOX INDIA PRIVATE LIMITED: COMPANY OVERVIEW 197.
TABLE 162 THALHEIMER KÜHLUNG FEZO: COMPANY OVERVIEW 198.
TABLE 163 B MEDICAL SYSTEMS : COMPANY OVERVIEW 199.
TABLE 164 STANDEX INTERNATIONAL CORPORATION: COMPANY OVERVIEW 200.
TABLE 165 EVERMED S.R.L: COMPANY OVERVIEW 201.
TABLE 166 ARCTIKO: COMPANY OVERVIEW 202.
TABLE 167 VESTFROST SOLUTIONS: COMPANY OVERVIEW 203.
TABLE 168 KW TECNILABO: COMPANY OVERVIEW 204.
TABLE 169 COLE PARMER: COMPANY OVERVIEW 205.
TABLE 170 ZHONGKE MEILING CRYOGENICS COMPANY LIMITED: COMPANY OVERVIEW 206.
TABLE 171 ESAW INDIA: COMPANY OVERVIEW 207.
TABLE 172 LABORATORY FREEZERS MARKET: RISK ANALYSIS 221.
FIGURE 1 LABORATORY FREEZERS MARKET SEGMENTATION AND REGIONAL SCOPE 24.
FIGURE 2 LABORATORY FREEZERS MARKET: YEARS CONSIDERED 25.
FIGURE 3 MARKET SCENARIO 27.
FIGURE 4 GLOBAL LABORATORY FREEZERS MARKET, 2024–2031 27.
FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN LABORATORY FREEZERS MARKET, 2023–2025 28.
FIGURE 6 DISRUPTIONS INFLUENCING GROWTH OF LABORATORY FREEZERS MARKET 29.
FIGURE 7 HIGH-GROWTH SEGMENTS IN LABORATORY FREEZERS MARKET, 2026–2031 30.
FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN LABORATORY FREEZERS MARKET DURING FORECAST PERIOD 31.
FIGURE 9 EXPANSION OF BIOPHARMACEUTICAL RESEARCH AND COLD-STORAGE REQUIREMENTS TO DRIVE MARKET 32.
FIGURE 10 US AND FREEZERS ACCOUNTED FOR LARGEST SHARE IN NORTH AMERICA IN 2025 33.
FIGURE 11 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 34.
FIGURE 12 LABORATORY FREEZERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 36.
FIGURE 13 IMPACT OF PORTER’S FIVE FORCES ON LABORATORY FREEZERS MARKET 41.
FIGURE 14 LABORATORY FREEZERS MARKET: SUPPLY CHAIN ANALYSIS 44.
FIGURE 15 LABORATORY FREEZERS MARKET: VALUE CHAIN ANALYSIS 46.
FIGURE 16 LABORATORY FREEZERS MARKET: ECOSYSTEM ANALYSIS 47.
FIGURE 17 AVERAGE SELLING PRICE OF LABORATORY FREEZERS, BY REGION, 2025 (USD THOUSAND) 50.
FIGURE 18 IMPORT SCENARIO FOR HS CODE 841840, 2021–2025 (USD MILLION) 51.
FIGURE 19 EXPORT SCENARIO FOR HS CODE 841840, 2021–2025 (USD MILLION) 52.
FIGURE 20 LABORATORY FREEZERS MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 55.
FIGURE 21 FUNDING SCENARIO AND NUMBER OF DEALS IN LABORATORY FREEZERS MARKET, 2019–2023 55.
FIGURE 22 NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 56.
FIGURE 23 VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 (USD MILLION) 56.
FIGURE 24 LABORATORY FREEZERS MARKET: PATENT ANALYSIS, 2015–2025 62.
FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT 79.
FIGURE 26 KEY BUYING CRITERIA FOR LABORATORY FREEZER PRODUCTS 80.
FIGURE 27 NORTH AMERICA: LABORATORY FREEZERS MARKET SNAPSHOT 114.
FIGURE 28 ASIA PACIFIC: LABORATORY FREEZERS MARKET SNAPSHOT 126.
FIGURE 29 REVENUE ANALYSIS OF KEY PLAYERS IN LABORATORY FREEZERS MARKET, 2021–2025 (USD MILLION) 146.
FIGURE 30 SHARE ANALYSIS OF KEY PLAYERS IN LABORATORY FREEZERS MARKET, 2025 146.
FIGURE 31 RANKING OF KEY PLAYERS IN LABORATORY FREEZERS MARKET, 2025 148.
FIGURE 32 EV/EBITDA OF TOP KEY PLAYERS (2026) 148.
FIGURE 33 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF TOP THREE PLAYERS (2026) 149.
FIGURE 34 LABORATORY FREEZERS: BRAND/PRODUCT COMPARATIVE ANALYSIS 150.
FIGURE 35 LABORATORY FREEZERS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 152.
FIGURE 36 LABORATORY FREEZERS MARKET: COMPANY FOOTPRINT 153.
FIGURE 37 LABORATORY FREEZERS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 157.
FIGURE 38 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025) 164.
FIGURE 39 HAIER BIOMEDICAL: COMPANY SNAPSHOT (2025) 167.
FIGURE 40 PHC HOLDINGS CORPORATION: COMPANY SNAPSHOT (2025) 172.
FIGURE 41 EPPENDORF SE: COMPANY SNAPSHOT (2025) 176.
FIGURE 42 AVANTOR, INC.: COMPANY SNAPSHOT (2025) 180.
FIGURE 43 FOLLETT PRODUCTS, LLC: COMPANY SNAPSHOT (2025) 185.
FIGURE 44 LIEBHERR: COMPANY SNAPSHOT (2025) 188.
FIGURE 45 BLUE STAR LIMITED: COMPANY SNAPSHOT (2025) 193.
FIGURE 46 LABORATORY FREEZERS MARKET: RESEARCH DATA 208.
FIGURE 47 LABORATORY FREEZERS MARKET: RESEARCH DESIGN 209.
FIGURE 48 LABORATORY FREEZERS MARKET: KEY SECONDARY SOURCES 211.
FIGURE 49 LABORATORY FREEZERS MARKET: KEY DATA FROM SECONDARY SOURCES 211.
FIGURE 50 LABORATORY FREEZERS MARKET: KEY PRIMARY SOURCES (DEMAND AND SUPPLY SIDES) 212.
FIGURE 51 LABORATORY FREEZERS MARKET: KEY SUPPLY- AND DEMAND-SIDE PARTICIPANTS 212.
FIGURE 52 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 213.
FIGURE 53 LABORATORY FREEZERS MARKET: KEY INSIGHTS FROM PRIMARY EXPERTS 214.
FIGURE 54 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 215.
FIGURE 55 LABORATORY FREEZERS MARKET: COMPANY REVENUE ESTIMATION, 2025 216.
FIGURE 56 LABORATORY FREEZERS MARKET: MARKET SIZE ESTIMATION METHODOLOGY 217.
FIGURE 57 LABORATORY FREEZERS MARKET: GROWTH PROJECTIONS BASED ON REVENUE IMPACT OF KEY MACRO INDICATORS 218.
FIGURE 58 DATA TRIANGULATION 219.